Schrodinger Inc. Stock
€22.42
Your prediction
Schrodinger Inc. Stock
Pros and Cons of Schrodinger Inc. in the next few years
Pros
Cons
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Schrodinger Inc., a company operating in the industry, appears to have experienced notable changes in its financial performance over the past few years. Upon an initial review of the available financial statements, it can be observed that the company is managing significant assets and revenues. However, it is also facing challenges in various aspects of its operations, including increasing expenses and fluctuating cash flow.
Growth in Total Assets: Schrodinger's total assets have been increasing consistently over the past few years. From 2020 to 2022, total assets grew from $746 million to $838 million, which demonstrates the company's ability to grow its asset base.
Increase in Revenue: Revenue has been steadily rising for Schrodinger, with total revenue increasing from $108 million in 2020 to $180 million in 2022. This upward trend indicates that the company has been successful in expanding its market presence and growing its business.
News
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2024 financial results on
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its MALT1